Rebate increase welcome, but not enough: RACGP A $187 million increase to Medicare rebates comes into effect this week, but the RACGP argues it does not fully address long-term underfunding of general practice.
New financial year: What GPs need to know With a number of key legislative changes to be implemented from 1 July, newsGP breaks down the ones that will affect general practice.
Increase to NDIS price limits good news for rural providers The Federal Government has announced a spending boost to the scheme, with particular benefits for service providers in rural and remote areas.
Behind the scenes at the PBAC Outgoing RACGP representative Rashmi Sharma pulls back the curtain after 10 years on the Pharmaceutical Benefits Advisory Committee.
GP resistance to nurse practitioner Medicare push The RACGP has flagged its opposition to a proposal that nurse practitioners be granted more autonomy in patient treatment.
Protecting your practice from a notifiable data breach The RACGP has again collaborated with the Office of the Australian Information Commissioner for Privacy Awareness Week.
Old doc, new data: Canaglifozin Can-I-get-a-flozin? Dr Casey Parker examines new evidence for the diabetes medication.
Metabolic disorder drug listed on the PBS The listing will save patients with hyperphenylalaninemia more than $90,000 a year.
Government’s NDIS growth figures ‘pretty meaningless’: GP Dr James Best discusses the gap between the Government’s positive depiction of the NDIS and the experiences of people navigating the scheme.
Potentially ‘life changing’ arthritis drug listed on PBS Tofacitinib will be listed despite lingering concerns related to an increased risk of blood clots and potentially death when taken in high doses.